ZMYND8 is a master regulator of 27-hydroxycholesterol that promotes tumorigenicity of breast cancer stem cells

M Luo, L Bao, Y Chen, Y Xue, Y Wang, B Zhang… - Science …, 2022 - science.org
27-Hydroxycholesterol (27-HC) is the most abundant oxysterol that increases the risk of
breast cancer progression. However, little is known about epigenetic regulation of 27-HC …

Endogenous estrogen receptor modulating oxysterols and breast cancer prognosis: Results from the MARIE patient cohort

NS Decker, T Johnson, S Behrens, N Obi… - British journal of …, 2023 - nature.com
Abstract Background 27-hydroxycholesterol (HC) and 25-HC were identified as endogenous
selective estrogen receptor modulators (SERMs) and estrogen receptor (ER) modulators …

Liver X Receptors (LXRs) in cancer-an Eagle's view on molecular insights and therapeutic opportunities

PS Ramalingam, S Elangovan, JR Mekala… - Frontiers in Cell and …, 2024 - frontiersin.org
Cancer has become a serious health burden that results in high incidence and mortality
rates every year, mainly due to various molecular alterations inside the cell. Liver X …

DHCR7 promotes tumorigenesis via activating PI3K/AKT/mTOR signalling pathway in bladder cancer

Y Li, Y Zhou, M Huang, Z Wang, D Liu, J Liu, X Fu… - Cellular signalling, 2023 - Elsevier
Bladder cancer (BCa) is a common malignancy with uncertain molecular mechanism. 7-
dehydrocholesterol reductase (DHCR7), the enzyme of mammalian sterol biosynthesis …

Identifying the transcriptional drivers of metastasis embedded within localized melanoma

S Suresh, R Rabbie, M Garg, D Lumaquin, TH Huang… - Cancer discovery, 2023 - AACR
In melanoma, predicting which tumors will ultimately metastasize guides treatment
decisions. Transcriptional signatures of primary tumors have been utilized to predict …

[HTML][HTML] NR0B2 re-educates myeloid immune cells to reduce regulatory T cell expansion and progression of breast and other solid tumors

HEV Gamage, SH Shahoei, Y Wang, E Jacquin… - Cancer Letters, 2024 - Elsevier
Although survival from breast cancer has dramatically increased, many will develop
recurrent, metastatic disease. Unfortunately, survival for this stage of disease remains very …

[HTML][HTML] Development of NR0B2 as a therapeutic target for the re-education of tumor associated myeloid cells

HEV Gamage, ST Albright, AJ Smith, R Farmer… - Cancer Letters, 2024 - Elsevier
Immune checkpoint blockade (ICB) has had limited utility in several solid tumors such as
breast cancer, a major cause of cancer-related mortality in women. Therefore, there is …

[HTML][HTML] Re-education of myeloid immune cells to reduce regulatory T cell expansion and impede breast cancer progression

HEV Gamage, SH Shahoei, ST Albright, Y Wang… - bioRxiv, 2023 - ncbi.nlm.nih.gov
Immune checkpoint blockade (ICB) has revolutionized cancer therapy but has had limited
utility in several solid tumors such as breast cancer, a major cause of cancer-related …

Neutrophils exposed to a cholesterol metabolite secrete extracellular vesicles that promote epithelial-mesenchymal transition and stemness in breast cancer cells.

N Krawczynska, Y Wang, K Lim, A Das Gupta… - bioRxiv, 2024 - biorxiv.org
Small extracellular vesicles (sEVs) are emerging as critical mediators of intercellular
communication in the tumor microenvironment (TME). Here, we investigate the mechanisms …